Last Updated: May 10, 2026

SORBITOL 3.3% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sorbitol 3.3% In Plastic Container patents expire, and when can generic versions of Sorbitol 3.3% In Plastic Container launch?

Sorbitol 3.3% In Plastic Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in SORBITOL 3.3% IN PLASTIC CONTAINER is sorbitol. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sorbitol profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for SORBITOL 3.3% IN PLASTIC CONTAINER?
  • What are the global sales for SORBITOL 3.3% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for SORBITOL 3.3% IN PLASTIC CONTAINER?
Summary for SORBITOL 3.3% IN PLASTIC CONTAINER
Recent Clinical Trials for SORBITOL 3.3% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Applied Therapeutics, Inc.PHASE3
Sunnybrook Health Sciences CentrePHASE3
Empros Pharma ABPHASE2

See all SORBITOL 3.3% IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for SORBITOL 3.3% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun SORBITOL 3.3% IN PLASTIC CONTAINER sorbitol SOLUTION;IRRIGATION 016741-001 Approved Prior to Jan 1, 1982 RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Sorbitol 3.3% in Plastic Container

Last updated: March 1, 2026

What is the Market Size and Growth for Sorbitol 3.3% in Plastic Containers?

The global market for sorbitol solutions, including 3.3% concentrations in plastic containers, is primarily driven by its application in food, pharmaceuticals, and personal care. The market valuation was approximately USD 1.5 billion in 2022, with a Compound Annual Growth Rate (CAGR) projected at 5.2% from 2023 to 2030.

Key factors influencing growth include rising demand for low-calorie sweeteners, increasing use in formulations of oral care products, and expanding pharmaceutical applications. The Asia Pacific, led by China and India, contributes over 40% of market volume, driven by rising health awareness and manufacturing capacity.

Who Are the Leading Players and What Are Their Market Shares?

Major manufacturers include:

Company Estimated Market Share Key Features
Ingredion 25% Large product portfolio, global distribution
Roquette 20% Focus on pharmaceutical-grade sorbitol
Cargill 15% Innovation in niche applications
ADM 10% Cost advantage in bulk production

Smaller players and regional manufacturers account for the remaining 30%, primarily serving local or specialty markets.

What Are the Key Drivers and Constraints?

Drivers:

  • Food & Beverage Industry: Sorbitol's use as a sweetener and humectant in candies, gum, and baked goods. The demand for sugar-free products fuels sales.
  • Pharmaceutical Sector: Usage in syrups, chewable tablets, and excipients. Regulatory approvals for pharmaceutical-grade sorbitol expand market penetration.
  • Oral Care: Component in toothpaste and mouthwashes due to cavity-reducing and moisturizing properties.
  • Personal Care: Employed in lotions and skincare products as a humectant.

Constraints:

  • Regulatory Hurdles: Stringent regulations in Europe and North America affecting manufacturing standards.
  • Price Volatility: Raw material costs, primarily derived from corn and other carbohydrate sources, influence pricing.
  • Environmental Concerns: Waste management and sustainability issues linked with plastic packaging.

How Does Packaging Impact Market Dynamics?

The use of plastic containers, particularly polyethylene terephthalate (PET) bottles and pouches, influences distribution and consumer acceptance. Innovations in biodegradable plastics and sustainable packaging are increasingly adopted to address environmental concerns, promising future market differentiation.

What Are the Financial Trends and Investment Opportunities?

Market revenue is expected to reach USD 2.3 billion by 2030. Key investment avenues include:

  • Product Innovation: Development of high-purity, pharmaceutical-grade sorbitol with enhanced stability.
  • Sustainable Packaging: Adoption of biodegradable and recyclable containers to meet regulatory standards.
  • Regional Expansion: Entry into emerging markets with rising applications in food and personal care.

Margins vary from 10% to 15%, influenced by raw material costs and scale efficiencies. Companies that optimize supply chains and invest in R&D to meet tighter regulations position for growth.

What Are Regulatory and Patent Considerations?

Regulatory approval from agencies such as the US FDA, EFSA, and China SFDA is necessary, especially for pharmaceutical-grade sorbitol. No recent major patent filings restrict the primary manufacturing methods, but patents related to packaging and formulation enhancements exist.

What Are the Future Market Opportunities and Risks?

Opportunities include increasing applications in nutraceuticals, biodegradable packaging integration, and health-conscious product formulations. Risks encompass potential trade restrictions, fluctuating raw material prices, and environmental regulations impacting plastic use.


Key Takeaways

  • The global sorbitol 3.3% market is valued at USD 1.5 billion (2022), with 5.2% CAGR projected through 2030.
  • Asia Pacific dominates the market, supported by manufacturing growth and consumer demand.
  • Leading firms control over 60% of the market, with innovation and sustainability as competitive differentiators.
  • Regulatory dynamics and raw material pricing are primary market influencers.
  • Future growth depends on product innovation, sustainable packaging, and expansion into new regional markets.

FAQs

Q1: What are the primary applications of sorbitol 3.3% solutions?
A1: They are used in food products as sweeteners, in pharmaceuticals as excipients, and in personal care as humectants.

Q2: How does packaging impact the market?
A2: Plastic containers facilitate distribution but environmental concerns drive demand for biodegradable options.

Q3: What are the main growth regions?
A3: The Asia Pacific leads due to expanding manufacturing base, followed by North America and Europe.

Q4: What are regulatory hurdles?
A4: Compliance with food and pharmaceutical standards from agencies like the FDA, EFSA, and local agencies.

Q5: What is the outlook for investment returns?
A5: Revenue growth is expected to reach USD 2.3 billion by 2030, with margins around 10-15%.


References

  1. MarketsandMarkets. (2022). Sorbitol market size, share, trends, research report.
  2. Grand View Research. (2023). Low-calorie sweeteners market analysis.
  3. U.S. Food and Drug Administration (FDA). (2023). Food additive regulations for sorbitol.
  4. European Food Safety Authority (EFSA). (2022). Safety evaluation of sorbitol.
  5. Asian Development Bank. (2022). Manufacturing and supply chain analysis in Asia-Pacific.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.